期刊文献+

辛伐他汀对高脂血症患者血浆C反应蛋白水平的影响 被引量:2

下载PDF
导出
摘要 目的研究辛伐他汀对高脂血症患者血浆C反应蛋白(CRP)的影响。方法测定131例高脂血症患者辛伐他汀治疗前后血脂、CRP水平的变化。结果经辛伐他汀治疗12周后,总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、脂蛋白a(LP(a))、CRP分别下降12.67%、20.28%、20.83%、33.32%、25.74%,而高密度脂蛋白胆固醇(HDL-C)升高20.66%,差异均有统计学意义(P<0.01)。结论辛伐他汀不仅能调节血脂,还能降低血浆CRP。
作者 顾强 孙康云
出处 《苏州大学学报(医学版)》 CAS 北大核心 2007年第4期623-624,共2页 Suzhou University Journal of Medical Science
  • 相关文献

参考文献5

  • 1Roivainen M,Kajander MV,Palosuo T,et al.Infections,inflammation,and the risk of coronary heart disease[J].Circulation,2000,101(3):252-255.
  • 2金凤表,侯瑞田,蒋宝琦,吴彦.阿托伐他汀的非调脂作用[J].心血管病学进展,2003,24(2):125-127. 被引量:22
  • 3Morrow DA,Rider PM.C-reactive protein inflammation,and coronary risk[J].Med Clin North Am,2000,84 (1):149-161.
  • 4Pasceri V,Willerson JT,Yeh ET.Direct proinflammatory effect of C-reactive protein on human endothelia cells[J].Circulation,2000,102(18):2165-2169.
  • 5Ridker PM,Rifai N,Pfeffer MA,et al.Inflammation,pravastatin,and the risk of coronary events after myocardial infarction in patients with average cholesterol levels[J].Circulation,1998,98 (9):839-844.

二级参考文献13

  • 1[1]Wilcox LJ, Barrett PH, Huff MW. Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin[J]. J Lipid Res, 1999,40(6) :1078-1089.
  • 2[2]Elkin RG, Yan Z ,Zhong Y, et al. Select 3-hydroxy-3-methylglutary 1-coenzyme A reductase inhibitors vary in their ability to reduce egg yolk cholesterol levels in laying hens through alteration of hepatic cholesterol biosynthesis and plasma VLDL composition[J].J Nutr, 1999,129(5) :1010-1019.
  • 3[3]Alfon J, Guasch JF, Berrozpe M,et al. Nitric oxide synthase Ⅱ(NOS Ⅱ ) gene expreuion correlates with atherosclerotic intimal thickening. Preventive effects of HMG-CoA reductase inhibitors[J]. Atherosclerosis, 1999,145 (2) :325 -331.
  • 4[4]Wagner AH, Kohler T, Ruckschloss U,et al. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial auperoxide anion formation [J]. Arterioscler Thromb Vasc Biol,2000,20( 1 ) :61-69.
  • 5[5]Bustos C, Hernandez-Presa MA, Orteqo M,et al. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis[ J ]. J Am Coll Cardiol, 1998,32 (7) :2057-2064.
  • 6[6]Park HJ, Galper JB. 3-Hydroxy-3-methylglutary1 CoA reductase inhibitors upregulate transforming growth factor-beta signaling in cultured heart cells via inhibition of geranylgeranylation of RhoA GTPase. Proc Natl Acad Sci USA [ J ].1999,96(20) :11525-11530.
  • 7[7]Strandberg TE,Vanhanen H, Tikkanen MJ. Effect of statins on C-reactive protein in patients with coronary heart disease[J]. Lancet, 1999,353:118-119.
  • 8[8]Tesfamariam B, Frohlich BH, Gregg RE. Differential effects of pravastatin,simvastatin, and atorvastatin on Ca2 + release and vascular reactivity[J]. J Cardiovasc Pharmacol, 1999,34( 1 ) :95-101.
  • 9[9]Niekenig G, Baumer AT, Temur Y, et al. Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men[J].Circulation. 1999.100(21 ) :2131-2134.
  • 10[10]Alfon J, Pueyo Palazon C, Royo T,et al. Effects of statins in thrombosis and aortic lesion development in a dyslipemic rabbit model[J]. Thromb Haemost,1999,81 (5) :822-827.

共引文献21

同被引文献23

  • 1张传海,苏美庆.血脂康的药理与临床研究进展[J].河北医药,2004,26(11):911-912. 被引量:15
  • 2任景怡,陈红,罗宇.联合应用辛伐他汀和非诺贝特治疗混合性高脂血症的疗效及安全性观察[J].中华心血管病杂志,2005,33(2):122-126. 被引量:42
  • 3谢洪智,朱文玲.冠状动脉病变与代谢综合征及高敏C反应蛋白关系的探讨[J].中华心血管病杂志,2007,35(6):527-530. 被引量:14
  • 4Pasceri V, Cheng JS, Willerson JT, et al. Modulation of Creactive protein-mediated monocyte chemoattractant protein-1 induction human endothelial cells by anti-atheroscleros is drugs [J]. Circulation, 2001,103(21) :2531-2534.
  • 5Zwaka TP, Hombach V, Torzewski J. C-reactive protein mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis[J]. Circulation, 2001,103 (9) : 1194-1197.
  • 6de Vries J. Thijssen WA. Snels SE. et al. lntraoperative values of S-100 protein, myelin basic protein, lactate, and albumin in the CSF and serum of neurosurgieal patients [ J ]. J Neurol Neurosurg Psychiatry, 2001,71 (5) : 671-674.
  • 7Ross R. Atherosclerosis is an inflammatory disease[J]. Am Heart J,1999,138(5 Pt 2) :S419-420.
  • 8Laman JD, Schoneveld AH, Moll FL, et al. Significance of peptidoglycan, a proinflammatory bacterial antigen in atherosclerotic arteries and its association with vulnerable plaques[J]. Am J Cardiol, 2002,90(2) : 119-123.
  • 9Guba SC, Fink I.M, Fonseca V. Hyperhomocysteinemia. An emerging and important risk factor for thromboembolic and cardiovasculardisease[J]. Am J Clin Pathol, 1996, 106(6):709-722.
  • 10Farnier M. Combination therapy with an HMG-CoA reductase inhibitor and a fibric acid derivative., a critical review of potential benefits and drawbacks[J]. Am J Cardiovasc Drugs, 2003,3(3) :169-178.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部